I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Novel third-generation tyrosine kinase inhibitor for newly ..:
Tan, Xu
;
Wen, Qin
;
Chen, Guo
...
Anti-Cancer Drugs. , 2022
Link:
https://doi.org/10.1097/cad.0000000000001455
RT Journal T1 <Title>Novel third-generation tyrosine kinase inhibitor for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a case study</Title> UL https://suche.suub.uni-bremen.de/peid=cr-10.1097_cad.0000000000001455&Exemplar=1&LAN=DE A1 Tan, Xu A1 Wen, Qin A1 Chen, Guo A1 Wan, Kai A1 Liu, Xue A1 Ma, Ying-Ying A1 Wang, Mai-Hong A1 Zhang, Xi A1 Zhang, Cheng PB Ovid Technologies (Wolters Kluwer Health) YR 2022 SN 0959-4973 JF Anti-Cancer Drugs LK http://dx.doi.org/https://doi.org/10.1097/cad.0000000000001455 DO https://doi.org/10.1097/cad.0000000000001455 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
